Cavin3 Suppresses Breast Cancer Metastasis via Inhibiting AKT Pathway

PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges

(2019) Mohammad A. Khan et al.   DRUG DISCOVERY TODAY

Distinct functions of AKT isoforms in breast cancer: a comprehensive review

(2019) Nico Hinz et al.   Cell Communication and Signaling

Dithiolethiones: a privileged pharmacophore for anticancer therapy and chemoprevention

(2018) Mohd Imran Ansari et al.   Future Medicinal Chemistry

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer

(2017) Swathi Ramakrishnan et al.   Cell Death & Disease

Prognostic and Diagnostic Significance of SDPR-Cavin-2 in Hepatocellular Carcinoma

(2016) Wei Jing et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis

(2016) Sait Ozturk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

(2015) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epigenetic treatment of solid tumours: a review of clinical trials

(2015) Clara Nervi et al.   Clinical Epigenetics

Caveolin and cavin family members: Dual roles in cancer

(2014) Reshu Gupta et al.   BIOCHIMIE

Regulation of intracellular signaling and function by caveolin

(2014) Heidi N. Fridolfsson et al.   FASEB JOURNAL

Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer

(2013) Catia Moutinho et al.   JNCI-Journal of the National Cancer Institute

Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer

(2013) L Liu et al.   ONCOGENE

Cavin-3 dictates the balance between ERK and Akt signaling

(2013) Victor J Hernandez et al.   eLife

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases

(2012) Harriet Wikman et al.   PLoS One

An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease spread and epithelial Akt activation

(2011) Dolores Di Vizio et al.   CELL CYCLE

Epigenetic Alteration of PRKCDBP in Colorectal Cancers and Its Implication in Tumor Cell Resistance to TNF -Induced Apoptosis

(2011) J.-H. Lee et al.   CLINICAL CANCER RESEARCH

Down-regulation of the cavin family proteins in breast cancer

(2011) Lin Bai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Frequent inactivation ofhSRBCin ovarian cancers by promoter CpG island hypermethylation

(2010) Seo-Yun Tong et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer

(2010) Agnieszka K. Witkiewicz et al.   CANCER BIOLOGY & THERAPY

PTRF–cavin-1 expression decreases the migration of PC3 prostate cancer cells: Role of matrix metalloprotease 9

(2010) Cho Sanda Aung et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers

(2009) Agnieszka K. Witkiewicz et al.   AMERICAN JOURNAL OF PATHOLOGY

Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma

(2008) H Zhang et al.   BRITISH JOURNAL OF CANCER